Headed by Harvard University geneticist George Church, US-based firm eGenesis is working to adapt pig organs so that they might be made suitable for transplant into human patients.
Headed by Harvard University geneticist George Church, US-based firm eGenesis is working to adapt pig organs so that they might be made suitable for transplant into human patients.